Drug Discovery Initiative (DDI) supports researchers testing novel or repurposed NF therapies and validating therapeutic targets to generate preliminary data and advance drug discovery.
Accelerating Drug Discovery for FTD supports investigators developing small molecule and biologic drugs through lead optimization and animal-model testing to advance disease-modifying treatments for FTD.
Accelerating Drug Discovery for Frontotemporal Degeneration supports researchers and clinicians developing small molecules and biologics to advance disease-modifying treatments for frontotemporal dementia.
Drug Discovery Award supports academic scientists with research resources and biopharma expertise to advance promising cancer targets toward new therapeutic agents and preclinical development.
Drug Discovery Predoctoral Fellowship supports advanced doctoral students pursuing novel, early-stage drug discovery research to develop safe, effective treatments with potential for human translation.
Cancer Research UK's CDD supports the development of novel cancer agents from preclinical stages to early clinical trials with expert resources, not monetary funding.